Journal article
F-18-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations
Viruses, Vol.13(11), 2283
11/01/2021
DOI: 10.3390/v13112283
PMCID: PMC8625263
PMID: 34835088
Abstract
Scientific evidence concerning the subacute and long-term effects of coronavirus disease 2019 (COVID-19) is on the rise. It has been established that infection by serious acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a systemic process that involves multiple organs. The complications and long-term consequences of COVID-19 are diverse and patients need a multidisciplinary treatment approach in the acute and post-acute stages of the disease. A significant proportion of COVID-19 patients experience neurological manifestations, some enduring for several months post-recovery. However, brain and skeletal muscle changes resultant from SARS CoV-2 infection remain largely unknown. Here, we provide a brief overview of the current knowledge, and usefulness, of [F-18]fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG-PET/CT) to investigate brain and skeletal muscles changes in Post-COVID-19 patients with persistent symptoms. Furthermore, a brief discussion of future F-18-FDG-PET/CT applications that might advance the current knowledge of the pathogenesis of post-COVID-19 is also provided.
Details
- Title: Subtitle
- F-18-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations
- Creators
- Thorsten Rudroff - University of IowaCraig D. Workman - University of IowaLaura L Boles Ponto - University of Iowa Hospitals and Clinics
- Resource Type
- Journal article
- Publication Details
- Viruses, Vol.13(11), 2283
- DOI
- 10.3390/v13112283
- PMID
- 34835088
- PMCID
- PMC8625263
- NLM abbreviation
- Viruses
- eISSN
- 1999-4915
- Publisher
- Mdpi
- Number of pages
- 9
- Language
- English
- Date published
- 11/01/2021
- Academic Unit
- Neurology; Radiology; Health, Sport, and Human Physiology
- Record Identifier
- 9984259398802771
Metrics
10 Record Views